American Society of Hematology
18
6
9
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.6%
1 terminated/withdrawn out of 18 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
86%
6 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
Role: collaborator
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
Role: collaborator
UPLYFT For Lymphoma Survivors
Role: collaborator
A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors
Role: collaborator
Hydroxyurea and EPO in Sickle Cell Disease
Role: collaborator
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
Role: collaborator
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
Role: collaborator
Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL
Role: collaborator
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Role: collaborator
Leukemia Adapted Protocol
Role: collaborator
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Role: collaborator
COVID-19 Vaccine Response in Sickle Cell Disease
Role: collaborator
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
Role: collaborator
Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
Role: collaborator
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Role: collaborator
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
Role: collaborator
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
Role: collaborator
The American Society of Hematology (ASH) Research Registry: A Multicenter Research Registry of Patients With Hematologic Disease
Role: lead
All 18 trials loaded